India to Australia: Hydroxychloroquine Export Trade Route
India has recorded 14 verified shipments of Hydroxychloroquine exported to Australia, representing a combined trade value of $1.1M USD. This corridor is served by 2 active Indian exporters, with an average shipment value of $76.4K USD. The leading Indian exporter is IPCA LABORATORIES LIMITED, which accounts for 93% of total export value with 13 shipments worth $996.4K USD. On the buying side, TO THE ORDER is the largest importer in Australia with $295.9K USD in purchases. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Australia Hydroxychloroquine corridor is one of India's established pharmaceutical export routes, with 14 shipments documented worth a combined $1.1M USD. The route is dominated by IPCA LABORATORIES LIMITED, which alone accounts for roughly 93% of all export value, reflecting the consolidated nature of India's hydroxychloroquine manufacturing sector.
Across 2 active suppliers, the average shipment value stands at $76.4K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (67%) and air (17%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during January–March, with an average transit time of 27 days port-to-port. The route has recorded an annual growth rate of 18.6%, placing it at rank #12 among India's top hydroxychloroquine export destinations globally.
On the import side, key buyers of Indian hydroxychloroquine in Australia include TO THE ORDER, IA, NA and 4 others. TO THE ORDER is the single largest importer with 6 shipments valued at $295.9K USD.
Route Characteristics
- Average transit27 days
- Peak seasonQ1
- Primary modeMulti-modal
- Top portNHAVA SHEVA
Market Position
- Global rank#12
- Annual growth+18.6%
- Demand growth+17.8%
- Regulatory ease68/100
Top 10 Indian Hydroxychloroquine Exporters to Australia
Showing top 10 of 2 Indian suppliers exporting Hydroxychloroquine to Australia, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | IPCA LABORATORIES LIMITED Avg $76.6K per shipment | 13 | $996.4K | 93.1% |
| 2 | IPCA LABORATORIES LIMITED Avg $73.8K per shipment | 1 | $73.8K | 6.9% |
This table shows the top 10 of 2 Indian companies exporting hydroxychloroquine to Australia, ranked by total trade value. The listed exporters are: IPCA LABORATORIES LIMITED, IPCA LABORATORIES LIMITED . IPCA LABORATORIES LIMITED is the dominant supplier with 13 shipments worth $996.4K USD, giving it a 93% market share.
Top 10 Hydroxychloroquine Importers in Australia
Showing top 10 of 7 known buyers in Australia receiving Hydroxychloroquine shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian hydroxychloroquine in Australia include TO THE ORDER, IA, NA, APOTEX PTY LTD, Arrow Pharmaceuticals Pty Ltd, , among 7 total buyers. The largest importer is TO THE ORDER, accounting for $295.9K USD across 6 shipments — representing 28% of all hydroxychloroquine imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | TO THE ORDER | 6 | $295.9K | 27.7% |
| 2 | IA | 1 | $212.5K | 19.9% |
| 3 | NA | 2 | $205.9K | 19.2% |
| 4 | APOTEX PTY LTD | 2 | $142.2K | 13.3% |
| 5 | Arrow Pharmaceuticals Pty Ltd, | 1 | $73.8K | 6.9% |
| 6 | ARROW PHARMACEUTICALS PTY LIMITED | 1 | $72.0K | 6.7% |
| 7 | ARROW PHARMACEUTICALS PTY LTD. | 1 | $68.0K | 6.3% |
Top 10 Hydroxychloroquine Formulations Imported by Australia
Showing top 10 of 9 product formulations shipped on the India to Australia Hydroxychloroquine route, ranked by trade value
Australia imports a wide range of hydroxychloroquine formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — HARMLESS MEDICINES:APO-HYDROXYCHLOROQUINE 200MG TABLETS(HYDROXYCHLOROQUINE SULFATE 200MG TABLETS)(29232X1X100'S PACK=292NOS — accounts for $295.9K USD across 6 shipments. A total of 9 product variants have been identified in the shipment records.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | HARMLESS MEDICINES:APO-HYDROXYCHLOROQUINE 200MG TABLETS(HYDROXYCHLOROQUINE SULFATE 200MG TABLETS)(29232X1X100'S PACK=292NOS | 6 | $295.9K | 27.7% |
| 2 | HARMLESS MEDICINES:APO-APO-HYDROXYCHLOROQUINE 200mg TabletsHydroxychloroquine sulfate tablets43890X1x100's PACK=43890 | 1 | $212.5K | 19.9% |
| 3 | HARMLESS MEDICINES:APO - HYDROXYCHLOROQUINE 200mg(Hydroxychloroquine sulfate tablets)(28668x1x100's PACK=2866800 TABLETS | 1 | $134.0K | 12.5% |
| 4 | HARMLESS MEDICINES Hydroxychloroquine | 1 | $73.8K | 6.9% |
| 5 | HARMLESS MEDICINES HEQUINEL Tablets 200mg Hydroxychloroquine Sulfate Tablets200mg 1x100s 14682X1x100s PACK UNIT | 1 | $72.0K | 6.7% |
| 6 | HARMLESS MEDICINES HEQUINEL TABLETS 200 MG (HYDROXYCHLOROQUINE SULFATE TABLETS200 MG) (1X100S) (14508X1X100S PACK) UN | 1 | $71.9K | 6.7% |
| 7 | HARMLESS MEDICINES APO HYDROXYCHLOROQUINE 200mg Hydroxychloroquine sulfatetablets 1x100s 14496X1x100s PACK UN | 1 | $71.8K | 6.7% |
| 8 | HARMLESS MEDICINES APO - HYDROXYCHLOROQUINE 200mg Tablets Hydroxychloroquinesulfate 200mg Tablets 1x100s 14646X1 | 1 | $70.4K | 6.6% |
| 9 | HARMLESS MEDICINES : HEQUINEL Tablets 200mg(Hydroxychloroquine Sulfate Tablets200mg) (1x100s) (14400x100s PAC | 1 | $68.0K | 6.3% |
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Balanced freight mix — 67% sea for bulk, 17% air for urgent orders.
Top Ports of Origin
NHAVA SHEVA handles the highest volume with 6 shipments. Transit time averages 27 days by sea.
Market Dynamics
India's hydroxychloroquine exports to Australia are driven primarily by a handful of large-scale manufacturers. IPCA LABORATORIES LIMITED with 13 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 2 active exporters signals a competitive but concentrated market — buyers in Australia benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — IPCA LABORATORIES LIMITED, IPCA LABORATORIES LIMITED — together account for 100% of total trade value on this route. The average shipment value of $76.4K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as harmless medicines:apo-apo-hydroxychloroquine 200mg tabletshydroxychloroquine sulfate tablets43890x1x100's pack=43890 and harmless medicines:apo - hydroxychloroquine 200mg(hydroxychloroquine sulfate tablets)(28668x1x100's pack=2866800 tablets, suggesting that buyers in Australia tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, TO THE ORDER is the largest importer with 6 shipments worth $295.9K USD — representing 28% of all hydroxychloroquine imports from India on this route. A total of 7 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $1.1M
- Avg. Shipment
- $76.4K
- Suppliers
- 2
- Buyers
- 7
- Transit (Sea)
- ~27 days
- Annual Growth
- +18.6%
Related Analysis
Other Hydroxychloroquine Routes
Unlock the Full India to Australia Hydroxychloroquine Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 14 shipments on this route.
Frequently Asked Questions — India to Australia Hydroxychloroquine Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Hydroxychloroquine to Australia?
The leading Indian exporters of Hydroxychloroquine to Australia are IPCA LABORATORIES LIMITED, IPCA LABORATORIES LIMITED . IPCA LABORATORIES LIMITED holds the largest market share at approximately 93% of total trade value on this route.
Q What is the total value of Hydroxychloroquine exports from India to Australia?
India exports Hydroxychloroquine to Australia worth approximately $1.1M USD across 14 recorded shipments. The average value per shipment is $76.4K USD.
Q Which ports does India use to ship Hydroxychloroquine to Australia?
The most active port of origin is NHAVA SHEVA with 6 shipments. Indian exporters primarily use a mix of sea and air freight for this route, with 67% of shipments going by sea and 17% by air.
Q How long does shipping take from India to Australia for Hydroxychloroquine?
The average transit time for Hydroxychloroquine shipments from India to Australia is approximately 27 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during January–March.
Q Is the India to Australia Hydroxychloroquine trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 18.6% with demand growth tracking at 17.8%. The route is ranked #12 among India's top Hydroxychloroquine export destinations globally.
Q How many suppliers are active on the India to Australia Hydroxychloroquine route?
There are currently 2 active Indian suppliers exporting Hydroxychloroquine to Australia. The market is moderately concentrated with IPCA LABORATORIES LIMITED accounting for 93% of total shipment value.
Q Who are the main importers of Hydroxychloroquine from India in Australia?
The leading importers of Indian Hydroxychloroquine in Australia include TO THE ORDER, IA, NA, APOTEX PTY LTD, Arrow Pharmaceuticals Pty Ltd, . TO THE ORDER is the largest buyer with 6 shipments worth $295.9K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Australia export trade corridor identified from Indian Customs (DGFT) records for Hydroxychloroquine.
- 2.Supplier/Buyer Matching: 2 Indian exporters and 7 importers in Australia matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 14 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
14 Verified Shipments
2 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists